Scarica l'app Stockscreener
56.05
5.38%
2.86
Dopo l'orario di chiusura:
56.10
0.05
+0.09%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$53.19
Aprire:
$53.73
Volume 24 ore:
15.68M
Relative Volume:
1.51
Capitalizzazione di mercato:
$70.53B
Reddito:
$368.91B
Utile/perdita netta:
$5.02B
Rapporto P/E:
8.454
EPS:
6.63
Flusso di cassa netto:
$1.69B
1 W Prestazione:
+0.43%
1M Prestazione:
-7.11%
6M Prestazione:
-2.83%
1 anno Prestazione:
-18.54%
Intervallo 1D:
$53.45
$56.78
Intervallo di 1 settimana:
$52.71
$56.78
Portata 52W:
$52.71
$83.25
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| CVS | 56.05 | 70.53B | 368.91B | 5.02B | 1.69B | 6.63 |
| UNH | 589.65 | 544.99B | 389.07B | 14.32B | 13.10B | 23.04 |
| ELV | 400.70 | 92.77B | 174.02B | 6.42B | 871.00M | 25.47 |
| CI | 322.45 | 89.32B | 229.75B | 3.04B | 5.18B | 17.73 |
| HUM | 271.35 | 32.67B | 115.01B | 1.36B | -4.34B | 24.12 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
CVS adds four new board members in deal with Glenview as CEO pursues a turnaround - Blue Water Healthy Living
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
Wachtell-Led CVS Adds Glenview CEO, Others To Board - Law360
Activist shareholder Glenview gains CVS board seat - The Business Journals
CVS Health Stock Is Moving Higher Monday: What's Going On? - Benzinga
CVS Health bulks its board up to 16 members, adds hedge fund CEO - AccessWDUN
CVS Expands Board Amid Investor Pressure, Adds Glenview CEO and Industry Experts - Yahoo Finance
CVS Health names four new board members in deal with activist investor Glenview Capital - Yahoo! Voices
CVS Adds Glenview’s Robbins to Board Under Activist Pressure - Yahoo Finance
CVS Adds Glenview’s Robbins to Board Under Activist Pressure (2) - Bloomberg Law
CVS Health adds 4 board members from hedge fund - Providence Business News
CVS Health Adds Four New Board Members - Inkl
Activist investor Glenview secures 4 board seats at CVS Health - Financial Times
CVS adds four new board members in deal with Glenview Capital - MSN
CVS adds Glenview Capital Management founder to board - Modern Healthcare
CVS adds four new board members in deal with Glenview as CEO pursues a turnaround By Reuters - Investing.com
CVS Health (NYSE:CVS) Upgraded by Wells Fargo & Company to "Overweight" Rating - MarketBeat
CVS strikes deal with activist Glenview Capital for four board seats - CNBC
CVS Health Corporation (CVS) Expands Board and Enhances Leadersh - GuruFocus.com
CVS Health gains as board grows on deal with activist investor Glenview - Proactive Investors UK
If You'd Invested $10,000 in Teladoc Stock 5 Years Ago, Here's How Much You'd Have Today - The Motley Fool
Short Interest in CVS Health Co. (NYSE:CVS) Increases By 5.0% - MarketBeat
AMG National Trust Bank Has $7.17 Million Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
11,030 Shares in CVS Health Co. (NYSE:CVS) Purchased by Aljian Capital Management LLC - MarketBeat
CVS Health Strengthens Board with Four Strategic Appointments After Glenview Talks | CVS Stock News - StockTitan
CVS Health upgraded to Overweight from Equal Weight at Wells Fargo - TipRanks
CVS Health Co. (NYSE:CVS) Stake Trimmed by Marathon Trading Investment Management LLC - MarketBeat
Seizert Capital Partners LLC Acquires 15,811 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Natixis Advisors LLC Purchases 170,566 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by CIBC Asset Management Inc - MarketBeat
GSA Capital Partners LLP Acquires Shares of 12,985 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health (NYSE:CVS) Sets New 1-Year Low Following Analyst Downgrade - MarketBeat
Ariz. Judge Will Decide Proper Venue For CVS Antitrust Suit - Law360
CVS Health Corp. stock outperforms competitors despite losses on the day - MarketWatch
CVS Health (NYSE:CVS) Price Target Cut to $58.00 by Analysts at Royal Bank of Canada - MarketBeat
RBC cuts CVS Health stock price target amid utilization headwinds - Investing.com
CVS stock touches 52-week low at $52.77 amid market shifts By Investing.com - Investing.com South Africa
CVS stock touches 52-week low at $52.77 amid market shifts - Investing.com
CVS Health price target lowered to $58 from $68 at RBC Capital - TipRanks
Valley Wealth Managers Inc. Increases Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Empowered Funds LLC Buys 72,228 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Are PBMs forcing out small drugstores, inflating medication prices? - Providence Business News
CVS Health Co. (NYSE:CVS) Shares Sold by ING Groep NV - MarketBeat
CVS Health (NYSE:CVS) Stock Unloaded Rep. Thomas R. Suozzi - MarketBeat
CVS Health (NYSE:CVS) Cut to Sell at StockNews.com - MarketBeat
CVS Health Stock Jumps After Mixed Q3 Earnings, Takes $1.2 Billion Restructuring Charges Hit - MSN
New CEO at CVS begins to build his team with a goal of reviving the struggling health care giant - Insight News
Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings - Reuters
CVS Health Gains Attention From Major Hedge Funds - Finimize
Focusing on value to deliver better care to Aetna® Medicare Advantage members - CVS Health
KBC Group NV Sells 1,251,527 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):